Form 4: DENTSPLY SIRONA Director Clyde Hosein Increases Beneficial Ownership Through RSU Dividends
Insider Transaction Report
DENTSPLY SIRONA Inc. Director Clyde Hosein acquired 222.26 additional restricted stock units as dividends, increasing his beneficial ownership to 40,611.3825 shares.
Summary
- Clyde Hosein, a Director of DENTSPLY SIRONA Inc. (XRAY), acquired 222.26 shares of Common Stock on July 11, 2025.
- This acquisition represents dividends on previously awarded restricted stock units (RSUs).
- The newly acquired RSUs are subject to the same vesting terms as the underlying awards and will vest simultaneously.
- Each RSU converts to common stock on a 1:1 basis.
- Following this transaction, Clyde Hosein directly beneficially owns 40,611.3825 shares.
- The Form 4 filing was signed by Jessica Causey, Attorney-in-Fact for Clyde Hosein, on July 15, 2025, under a Limited Power of Attorney dated May 22, 2025.
Sentiment
Score: 7
Explanation: The filing reports a routine acquisition of restricted stock units as dividends by a director, which increases their beneficial ownership and aligns their interests with shareholders. This is a standard compensation event and does not indicate any negative operational or financial issues.
Positives
- Director's beneficial ownership increased, further aligning interests with shareholders.
- Receipt of RSU dividends indicates ongoing compensation and retention of the director.
Future Outlook
The acquired restricted stock units (RSUs) are subject to the same vesting terms as the underlying awards and will vest simultaneously with them, converting to common stock on a 1:1 basis.
Industry Context
This Form 4 filing details a routine insider transaction related to director compensation and does not provide broader industry context or trends.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Authorization for SEC Filings | Clyde R. Hosein granted a Limited Power of Attorney to Richard Rosenzweig, Jessica Causey, and Lindi Barton-Brobst to execute and file Forms 3, 4, and 5 on his behalf for Section 16 reporting obligations. | 2025-05-22 | Enhances efficiency and compliance for insider trading reporting by authorizing company personnel to handle filings on behalf of the director. |
Related Party Transactions
- The acquisition of 222.26 restricted stock units by Director Clyde Hosein represents dividends on existing RSU awards, which is a form of compensation from DENTSPLY SIRONA Inc. to a related party (director).
Stakeholder Impact
- Shareholders: Increased alignment of director's interests with shareholders due to the increase in beneficial ownership.
Next Steps
- The acquired restricted stock units will vest according to their terms, converting to common stock.
Key Dates
| Date | Description |
|---|---|
| 2025-05-22 | Date of execution of the Limited Power of Attorney by Clyde R. Hosein. |
| 2025-07-11 | Date of the transaction where Clyde Hosein acquired additional restricted stock units as dividends. |
| 2025-07-15 | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
DENTSPLY SIRONA, XRAY, Form 4, Insider Transaction, Restricted Stock Units, RSU Dividends, Director Compensation, Beneficial Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.